GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » Enterprise Value

X Bioscience PCL (BKK:XBIO-W7) Enterprise Value : ฿961.8 Mil (As of Jul. 09, 2025) ***


View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, X Bioscience PCL's Enterprise Value is ฿961.8 Mil. X Bioscience PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ฿-276.1 Mil. Therefore, X Bioscience PCL's EV-to-EBIT ratio for today is -3.48.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, X Bioscience PCL's Enterprise Value is ฿961.8 Mil. X Bioscience PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ฿-196.7 Mil. Therefore, X Bioscience PCL's EV-to-EBITDA ratio for today is -4.89.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, X Bioscience PCL's Enterprise Value is ฿961.8 Mil. X Bioscience PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ฿305.9 Mil. Therefore, X Bioscience PCL's EV-to-Revenue ratio for today is 3.14.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, X Bioscience PCL's Enterprise Value is ฿961.8 Mil. X Bioscience PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ฿-78.7 Mil. Therefore, X Bioscience PCL's EV-to-FCF ratio for today is -12.22.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


X Bioscience PCL Enterprise Value Historical Data

The historical data trend for X Bioscience PCL's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL Enterprise Value Chart

X Bioscience PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

X Bioscience PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of X Bioscience PCL's Enterprise Value

For the Food Distribution subindustry, X Bioscience PCL's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


X Bioscience PCL's Enterprise Value Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, X Bioscience PCL's Enterprise Value distribution charts can be found below:

* The bar in red indicates where X Bioscience PCL's Enterprise Value falls into.


;
;

X Bioscience PCL Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

X Bioscience PCL's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

X Bioscience PCL's Enterprise Value for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


X Bioscience PCL  (BKK:XBIO-W7) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

X Bioscience PCL's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=961.835/-276.053
=-3.48

X Bioscience PCL's current Enterprise Value is ฿961.8 Mil.
X Bioscience PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-276.1 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

X Bioscience PCL's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=961.835/-196.671
=-4.89

X Bioscience PCL's current Enterprise Value is ฿961.8 Mil.
X Bioscience PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-196.7 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

X Bioscience PCL's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=961.835/305.853
=3.14

X Bioscience PCL's current Enterprise Value is ฿961.8 Mil.
X Bioscience PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿305.9 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

X Bioscience PCL's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=961.835/-78.712
=-12.22

X Bioscience PCL's current Enterprise Value is ฿961.8 Mil.
X Bioscience PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-78.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


X Bioscience PCL Enterprise Value Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


X Bioscience PCL Business Description

Traded in Other Exchanges
Address
Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines